<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NAS:CLVS (USA) Also Trade In: Germany

Clovis Oncology Inc $ 3.21 0.09 (2.72%)

Volume:
4,081,936
Avg Vol (1m):
3,814,495
Market Cap $:
175.45 Mil
Enterprise Value $:
472.47 Mil
P/E (TTM):
0.00
P/B:
0.00
Warning! GuruFocus has detected 2 Severe warning signs with CLVS. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

Financial Strength

1.8/10
Current Vs Industry Vs History
Cash-To-Debt 0.52
Equity-to-Asset -0.04
Debt-to-Equity -20.44
Debt-to-EBITDA -1.64
N/A
Piotroski F-Score 2
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -5.22
DISTRESS
GREY
SAFE
Beneish M-Score -1.95
Not Manipulator
Manipulator
WACC vs ROIC
ROIC -158.44 %
WACC 6.75 %

Profitability

1/10
Current Vs Industry Vs History
Operating Margin % -306.02
Net Margin % -332.18
ROE % -268.51
ROA % -47.21
ROC (Joel Greenblatt) % -1405.62
3-Year EBITDA Growth Rate 13.4
3-Year EPS without NRI Growth Rate 10.3

Ratios

Current Vs Industry Vs History
PS Ratio 1.4
EV-to-EBIT -1.22
N/A
EV-to-EBITDA -1.24
N/A
EV-to-Revenue 3.94
Current Ratio 3.57
Quick Ratio 3.32
Days Inventory 471.59
Days Sales Outstanding 47.08
Days Payable 235.44

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -10.7

Valuation & Return

Current Vs Industry Vs History
Price-to-Median-PS-Value 0.02
Earnings Yield (Greenblatt) % -80.66